ChIP-qPCR analysis confirmed the binding of FOXA1 to the predicted FOXA1 binding sites A/B and D and also to the binding site C in DLD1 and SW620 CRC cells (Fig. 3c-d). This evidence concerns the gene FOXA1 and colorectal carcinoma.